Today: 25 April 2026
X-Energy Stock Jumps in Nasdaq Debut as $1 Billion Nuclear IPO Tests AI Power Boom
25 April 2026
2 mins read

X-Energy Stock Jumps in Nasdaq Debut as $1 Billion Nuclear IPO Tests AI Power Boom

NEW YORK, April 25, 2026, 11:02 EDT

  • X-Energy’s Class A common shares ended Friday at $29.20, gaining almost 27% over the $23 IPO price.
  • Amazon-backed nuclear developer pulled in roughly $1.02 billion after bumping up the size of its offering.
  • Public investors now have a new small modular reactor stock to watch after the rally, though the company remains several years away from actual commercial deployment.

X-Energy Inc.’s Class A shares jumped on their Nasdaq debut, ending the session at $29.20. The Amazon-backed nuclear reactor firm had priced its expanded IPO at $23 apiece. That first-day close put the company’s market value near $11.9 billion, Reuters said, as buyers looked for exposure to AI- and data center-linked power plays.

Electricity demand is grabbing attention in markets, not just energy circles, making the listing newly relevant. X-Energy is pushing its small modular reactors—basically compact nuclear units designed for replication—as a potential source of reliable power for factories and hefty computing operations that can’t count solely on wind and solar.

X-Energy said late Thursday it pulled in roughly $1.02 billion from the sale of 44,254,659 Class A common shares. Shares debuted Friday on the Nasdaq Global Select Market, trading under the ticker “XE.” The deal is slated to close April 27, pending the usual conditions. X-energy

X-Energy priced its IPO above the previously marketed $16 to $19 range. The company also disclosed that underwriters secured a 30-day option to purchase as many as 6,638,198 additional shares.

J. Clay Sell, X-Energy’s Chief Executive, told Reuters the company’s public debut would open the door to greater transparency for both customers and investors. It’ll also provide stock to help attract and keep employees and free up capital for supply chain expansion. “We wanted to take this opportunity to build a larger balance sheet that allows us to reduce the risk of getting to scale,” Sell said. Reuters

X-Energy’s Xe-100 reactor relies on helium for cooling—unlike most reactors, which use water. The company is also betting on its nuclear fuel division, touting potential recurring revenue as more reactors come online.

The company’s initial commercial rollout is anchored by clients like Amazon, Dow, and Centrica. X-Energy disclosed in a securities filing that it’s collaborating with Dow and Amazon at its first announced locations—Seadrift, Texas and Richland, Washington. The company views subsequent projects as opportunities to reduce both costs and schedule risk by repeating what works.

The Dow project remains under regulatory review. Back in March 2025, a Dow subsidiary filed a construction permit application with the U.S. Nuclear Regulatory Commission. The agency officially docketed the request two months later, in May 2025, launching an 18-month review window. If the process stays on track and construction moves ahead, Dow has set its sights on commercial operation in the early 2030s.

X-Energy’s arrival gives it a spot alongside other publicly traded nuclear names like Oklo and NuScale Power—both part of the advanced-nuclear cohort. Oklo and NuScale shares slipped on Friday, according to MarketScreener’s Dow Jones page, while X-Energy’s fresh listing found buyers.

The risks, however, are far from trivial. X-Energy has informed investors that it hasn’t delivered a commercial Xe-100 reactor yet, nor has it made final investment decisions for any project. The company also cautioned that setbacks like licensing holdups, funding requirements, supply-chain snarls, and tight access to HALEU — that’s the high-assay low-enriched uranium fuel some advanced reactors need — could put a dent in its ambitions.

X-Energy, in its filing, signaled that losses will likely continue as the Xe-100 project moves from development to commercialization. The company flagged the potential need for additional funding—debt or equity down the line. Shares could be at risk if investors start to question whether the initial rally outpaced progress on licensing or the still-untested revenue stream.

Stock Market Today

  • Bitcoin $40,000 Bear Case Would Be Historic Outlier, Analyst Says
    April 25, 2026, 12:47 PM EDT. Bitcoin has gained nearly 15% this month, trading near $78,000, but remains 40% below its all-time high. Some forecasters predict a drop to $40,000, a 70% decline from its peak. Analyst James Check calls this scenario highly unlikely, labeling it a "0.4 event" on his Bitcoin Mean Reversion Index-a composite valuation model. Such a drop would rank in the 0.4th percentile historically, a rarity comparable to Bitcoin trading below $2 in 2011. Currently, Bitcoin's price sits at the 31.5th percentile, indicating weakness but still within normal correction ranges. Check warns the $40,000 prediction is near unprecedented in market history, underscoring the improbability of such a deep plunge.

Latest article

Sirius XM Holdings Inc. Deal Talks With iHeartMedia Could Reshape U.S. Audio Market

25 April 2026
NEW YORK, April 25, 2026, 12:07 EDT Sirius XM Holdings Inc. is in talks about a possible merger with iHeartMedia Inc., Bloomberg News reported, in a deal that would combine the largest U.S. satellite-radio company with the country’s biggest radio-station owner. The talks are preliminary and may not lead to a transaction, the report said; both companies declined to comment to Reuters. The timing matters. SiriusXM reports first-quarter results on April 30, and investors are watching whether last quarter’s return to self-pay subscriber growth can hold while the company pushes harder into advertising, podcasts and connected-car services. A tie-up would
Shake Shack Stock Gets a Fresh Wall Street Boost Before Earnings. Here’s What Changed

Shake Shack Stock Gets a Fresh Wall Street Boost Before Earnings. Here’s What Changed

25 April 2026
Guggenheim initiated Shake Shack at Buy with a $120 price target, citing margin upside and expansion potential. Shares rose 5.6% to $103.02. The call comes ahead of Shake Shack’s May 7 earnings report, with recent data showing first-quarter visits up nearly 20% year-over-year. JPMorgan raised its target to $100 but kept a Neutral rating, reflecting mixed analyst sentiment.
CRISPR Therapeutics Stock Just Lost 12%: What Casgevy Must Prove Next

CRISPR Therapeutics Stock Just Lost 12%: What Casgevy Must Prove Next

25 April 2026
CRISPR Therapeutics shares fell 11.6% Friday, closing at $48.79 with no new company disclosures. The company reported $116 million in 2025 Casgevy revenue and ended the year with $1.98 billion in cash. A June 4 shareholder meeting will vote on expanding the capital band and carrying forward a CHF 1.89 billion net loss. In March, CRISPR raised $536.3 million from a convertible notes offering.
China Warns U.S. Chip Export Bills Could Hit Global Semiconductor Supply Chains
Previous Story

China Warns U.S. Chip Export Bills Could Hit Global Semiconductor Supply Chains

The Trade Desk Stock Just Got a Short-Squeeze Signal. Earnings Could Decide the Next Move
Next Story

The Trade Desk Stock Just Got a Short-Squeeze Signal. Earnings Could Decide the Next Move

Go toTop